NEW YORK (

TheStreet

) --

Hi-Tech Pharmacal

(Nasdaq:

HITK

) hit a new 52-week high Wednesday as it is currently trading at $32.34, above its previous 52-week high of $32.13 with 162,238 shares traded as of 12:15 p.m. ET. Average volume has been 152,200 shares over the past 30 days.

Hi-Tech Pharmacal has a market cap of $385.8 million and is part of the

health care

sector and

drugs

industry. Shares are up 27.8% year to date as of the close of trading on Tuesday.

TheStreet Recommends

Hi-Tech Pharmacal Co., Inc. develops, manufactures, markets, and sells generic, prescription, over-the-counter (OTC), and nutritional products in liquid and semisolid dosage forms in the United States. The company has a P/E ratio of 9.1, below the average drugs industry P/E ratio of 9.5 and below the S&P 500 P/E ratio of 17.7.

  • Practice your HITK trading strategies and win cash in our stock game.

TheStreet Ratings rates Hi-Tech Pharmacal as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, compelling growth in net income, expanding profit margins and impressive record of earnings per share growth. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full

Hi-Tech Pharmacal Ratings Report

.

See all

52-week high stocks

or get investment ideas from our

investment research center

.

null